Bromine in PDB 3p3s: Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Protein crystallography data
The structure of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One, PDB code: 3p3s
was solved by
S.Connelly,
I.A.Wilson,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
50.00 /
1.60
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
44.110,
84.195,
64.888,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.4 /
23.2
|
Bromine Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
12;
Binding sites:
The binding sites of Bromine atom in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
(pdb code 3p3s). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 12 binding sites of Bromine where determined in the
Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One, PDB code: 3p3s:
Jump to Bromine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Bromine binding site 1 out
of 12 in 3p3s
Go back to
Bromine Binding Sites List in 3p3s
Bromine binding site 1 out
of 12 in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br128
b:30.8
occ:0.25
|
BRAE
|
A:3M2128
|
0.0
|
30.8
|
0.2
|
BRAF
|
A:3M2128
|
0.2
|
35.0
|
0.2
|
CAN
|
A:3M2128
|
1.7
|
25.0
|
0.2
|
CAM
|
A:3M2128
|
1.9
|
22.9
|
0.2
|
CAI
|
A:3M2128
|
2.5
|
25.7
|
0.2
|
CAK
|
A:3M2128
|
2.8
|
25.7
|
0.2
|
CAK
|
A:3M2128
|
2.8
|
25.7
|
0.2
|
CAH
|
A:3M2128
|
3.0
|
25.1
|
0.2
|
OAD
|
A:3M2128
|
3.0
|
28.5
|
0.2
|
OAD
|
A:3M2128
|
3.1
|
28.5
|
0.2
|
O
|
A:HOH157
|
3.7
|
38.0
|
1.0
|
NZ
|
A:LYS15
|
3.8
|
27.7
|
1.0
|
CAL
|
A:3M2128
|
3.9
|
25.6
|
0.2
|
CD1
|
A:LEU17
|
4.0
|
21.1
|
1.0
|
CAM
|
A:3M2128
|
4.0
|
22.9
|
0.2
|
CAN
|
A:3M2128
|
4.1
|
25.0
|
0.2
|
CE
|
A:LYS15
|
4.2
|
26.0
|
1.0
|
CAL
|
A:3M2128
|
4.3
|
25.6
|
0.2
|
CAH
|
A:3M2128
|
4.4
|
25.1
|
0.2
|
CAI
|
A:3M2128
|
4.7
|
25.7
|
0.2
|
CAG
|
A:3M2128
|
4.8
|
27.8
|
0.2
|
CAA
|
A:3M2128
|
4.8
|
33.4
|
0.2
|
|
Bromine binding site 2 out
of 12 in 3p3s
Go back to
Bromine Binding Sites List in 3p3s
Bromine binding site 2 out
of 12 in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br128
b:30.8
occ:0.25
|
BRAE
|
A:3M2128
|
0.0
|
30.8
|
0.2
|
BRAF
|
A:3M2128
|
0.2
|
35.0
|
0.2
|
CAN
|
A:3M2128
|
1.7
|
25.0
|
0.2
|
CAM
|
A:3M2128
|
1.9
|
22.9
|
0.2
|
CAI
|
A:3M2128
|
2.5
|
25.7
|
0.2
|
CAK
|
A:3M2128
|
2.8
|
25.7
|
0.2
|
CAK
|
A:3M2128
|
2.8
|
25.7
|
0.2
|
CAH
|
A:3M2128
|
3.0
|
25.1
|
0.2
|
OAD
|
A:3M2128
|
3.0
|
28.5
|
0.2
|
OAD
|
A:3M2128
|
3.1
|
28.5
|
0.2
|
CAL
|
A:3M2128
|
3.9
|
25.6
|
0.2
|
CG2
|
A:THR106
|
4.0
|
20.6
|
1.0
|
CAM
|
A:3M2128
|
4.0
|
22.9
|
0.2
|
CB
|
A:ALA108
|
4.0
|
17.8
|
1.0
|
CAN
|
A:3M2128
|
4.1
|
25.0
|
0.2
|
CAL
|
A:3M2128
|
4.3
|
25.6
|
0.2
|
CG2
|
A:VAL121
|
4.3
|
20.9
|
1.0
|
CD
|
A:LYS15
|
4.3
|
22.8
|
1.0
|
CAH
|
A:3M2128
|
4.4
|
25.1
|
0.2
|
O
|
A:HOH159
|
4.6
|
35.5
|
1.0
|
CAI
|
A:3M2128
|
4.7
|
25.7
|
0.2
|
CAG
|
A:3M2128
|
4.8
|
27.8
|
0.2
|
CAA
|
A:3M2128
|
4.8
|
33.4
|
0.2
|
CB
|
A:THR106
|
4.9
|
19.0
|
1.0
|
|
Bromine binding site 3 out
of 12 in 3p3s
Go back to
Bromine Binding Sites List in 3p3s
Bromine binding site 3 out
of 12 in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br128
b:35.0
occ:0.25
|
BRAF
|
A:3M2128
|
0.0
|
35.0
|
0.2
|
BRAE
|
A:3M2128
|
0.2
|
30.8
|
0.2
|
CAN
|
A:3M2128
|
1.9
|
25.0
|
0.2
|
CAM
|
A:3M2128
|
2.0
|
22.9
|
0.2
|
CAI
|
A:3M2128
|
2.7
|
25.7
|
0.2
|
CAK
|
A:3M2128
|
2.8
|
25.7
|
0.2
|
CAK
|
A:3M2128
|
2.9
|
25.7
|
0.2
|
OAD
|
A:3M2128
|
2.9
|
28.5
|
0.2
|
OAD
|
A:3M2128
|
3.1
|
28.5
|
0.2
|
CAH
|
A:3M2128
|
3.1
|
25.1
|
0.2
|
CG2
|
A:THR106
|
3.9
|
20.6
|
1.0
|
CAL
|
A:3M2128
|
4.0
|
25.6
|
0.2
|
CAM
|
A:3M2128
|
4.1
|
22.9
|
0.2
|
CAN
|
A:3M2128
|
4.2
|
25.0
|
0.2
|
CB
|
A:ALA108
|
4.2
|
17.8
|
1.0
|
CG2
|
A:VAL121
|
4.2
|
20.9
|
1.0
|
CD
|
A:LYS15
|
4.3
|
22.8
|
1.0
|
CAL
|
A:3M2128
|
4.4
|
25.6
|
0.2
|
O
|
A:HOH159
|
4.4
|
35.5
|
1.0
|
CAH
|
A:3M2128
|
4.6
|
25.1
|
0.2
|
CAI
|
A:3M2128
|
4.8
|
25.7
|
0.2
|
CB
|
A:THR106
|
4.8
|
19.0
|
1.0
|
CAG
|
A:3M2128
|
4.9
|
27.8
|
0.2
|
CAA
|
A:3M2128
|
5.0
|
33.4
|
0.2
|
|
Bromine binding site 4 out
of 12 in 3p3s
Go back to
Bromine Binding Sites List in 3p3s
Bromine binding site 4 out
of 12 in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 4 of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br128
b:35.0
occ:0.25
|
BRAF
|
A:3M2128
|
0.0
|
35.0
|
0.2
|
BRAE
|
A:3M2128
|
0.2
|
30.8
|
0.2
|
CAN
|
A:3M2128
|
1.9
|
25.0
|
0.2
|
CAM
|
A:3M2128
|
2.0
|
22.9
|
0.2
|
CAI
|
A:3M2128
|
2.7
|
25.7
|
0.2
|
CAK
|
A:3M2128
|
2.8
|
25.7
|
0.2
|
CAK
|
A:3M2128
|
2.9
|
25.7
|
0.2
|
OAD
|
A:3M2128
|
2.9
|
28.5
|
0.2
|
OAD
|
A:3M2128
|
3.1
|
28.5
|
0.2
|
CAH
|
A:3M2128
|
3.1
|
25.1
|
0.2
|
O
|
A:HOH157
|
3.6
|
38.0
|
1.0
|
NZ
|
A:LYS15
|
3.7
|
27.7
|
1.0
|
CAL
|
A:3M2128
|
4.0
|
25.6
|
0.2
|
CD1
|
A:LEU17
|
4.1
|
21.1
|
1.0
|
CE
|
A:LYS15
|
4.1
|
26.0
|
1.0
|
CAM
|
A:3M2128
|
4.1
|
22.9
|
0.2
|
CAN
|
A:3M2128
|
4.2
|
25.0
|
0.2
|
CAL
|
A:3M2128
|
4.4
|
25.6
|
0.2
|
CAH
|
A:3M2128
|
4.6
|
25.1
|
0.2
|
CAI
|
A:3M2128
|
4.8
|
25.7
|
0.2
|
CAG
|
A:3M2128
|
4.9
|
27.8
|
0.2
|
CAA
|
A:3M2128
|
5.0
|
33.4
|
0.2
|
|
Bromine binding site 5 out
of 12 in 3p3s
Go back to
Bromine Binding Sites List in 3p3s
Bromine binding site 5 out
of 12 in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 5 of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br129
b:28.2
occ:1.00
|
BRAE
|
A:3M2129
|
0.0
|
28.2
|
1.0
|
CAM
|
A:3M2129
|
1.9
|
22.8
|
1.0
|
CAK
|
A:3M2129
|
2.8
|
23.8
|
1.0
|
CAH
|
A:3M2129
|
2.8
|
21.8
|
1.0
|
OAD
|
A:3M2129
|
3.1
|
25.7
|
1.0
|
O
|
A:PHE64
|
3.3
|
20.9
|
1.0
|
O
|
A:HOH165
|
3.6
|
30.3
|
1.0
|
CB
|
A:ASN98
|
3.7
|
21.6
|
1.0
|
CA
|
A:VAL65
|
3.7
|
20.5
|
1.0
|
CG
|
A:ASN98
|
3.8
|
19.9
|
1.0
|
ND2
|
A:ASN98
|
3.9
|
20.1
|
1.0
|
N
|
A:GLU66
|
4.0
|
21.0
|
1.0
|
C
|
A:VAL65
|
4.0
|
21.0
|
1.0
|
CAN
|
A:3M2129
|
4.1
|
23.8
|
1.0
|
CB
|
A:PRO102
|
4.1
|
24.2
|
1.0
|
CAL
|
A:3M2129
|
4.2
|
23.1
|
1.0
|
CA
|
A:PRO102
|
4.2
|
22.9
|
1.0
|
C
|
A:PHE64
|
4.2
|
20.6
|
1.0
|
OD1
|
A:ASN98
|
4.3
|
22.4
|
1.0
|
N
|
A:VAL65
|
4.5
|
20.2
|
1.0
|
N
|
A:PRO102
|
4.5
|
22.5
|
1.0
|
CAI
|
A:3M2129
|
4.6
|
21.8
|
1.0
|
CD
|
A:PRO102
|
4.7
|
23.6
|
1.0
|
CB
|
A:VAL65
|
4.8
|
19.9
|
1.0
|
O
|
A:VAL65
|
4.8
|
20.9
|
1.0
|
CG
|
A:PRO102
|
4.8
|
24.4
|
1.0
|
CA
|
A:GLU66
|
5.0
|
21.1
|
0.4
|
|
Bromine binding site 6 out
of 12 in 3p3s
Go back to
Bromine Binding Sites List in 3p3s
Bromine binding site 6 out
of 12 in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 6 of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br129
b:29.3
occ:1.00
|
BRAF
|
A:3M2129
|
0.0
|
29.3
|
1.0
|
CAN
|
A:3M2129
|
1.9
|
23.8
|
1.0
|
CAK
|
A:3M2129
|
2.8
|
23.8
|
1.0
|
CAI
|
A:3M2129
|
2.9
|
21.8
|
1.0
|
OAD
|
A:3M2129
|
3.0
|
25.7
|
1.0
|
O
|
A:HOH168
|
3.8
|
38.1
|
1.0
|
CAM
|
A:3M2129
|
4.1
|
22.8
|
1.0
|
CAL
|
A:3M2129
|
4.2
|
23.1
|
1.0
|
CAH
|
A:3M2129
|
4.6
|
21.8
|
1.0
|
CD
|
A:PRO102
|
4.7
|
23.6
|
1.0
|
CAA
|
A:3M2129
|
4.9
|
22.9
|
1.0
|
CG
|
A:PRO102
|
5.0
|
24.4
|
1.0
|
|
Bromine binding site 7 out
of 12 in 3p3s
Go back to
Bromine Binding Sites List in 3p3s
Bromine binding site 7 out
of 12 in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 7 of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br128
b:36.0
occ:0.25
|
BRAE
|
B:3M2128
|
0.0
|
36.0
|
0.2
|
BRAF
|
B:3M2128
|
0.2
|
30.9
|
0.2
|
CAM
|
B:3M2128
|
1.9
|
25.5
|
0.2
|
CAN
|
B:3M2128
|
2.0
|
23.4
|
0.2
|
CAH
|
B:3M2128
|
2.7
|
24.9
|
0.2
|
CAK
|
B:3M2128
|
2.8
|
25.4
|
0.2
|
CAK
|
B:3M2128
|
2.8
|
25.4
|
0.2
|
OAD
|
B:3M2128
|
3.0
|
26.2
|
0.2
|
CAI
|
B:3M2128
|
3.1
|
23.7
|
0.2
|
OAD
|
B:3M2128
|
3.1
|
26.2
|
0.2
|
NZ
|
B:LYS15
|
3.6
|
29.5
|
1.0
|
CD1
|
B:LEU17
|
4.0
|
21.5
|
1.0
|
CAL
|
B:3M2128
|
4.0
|
24.6
|
0.2
|
CE
|
B:LYS15
|
4.1
|
27.8
|
1.0
|
CAN
|
B:3M2128
|
4.1
|
23.4
|
0.2
|
CAM
|
B:3M2128
|
4.1
|
25.5
|
0.2
|
CAL
|
B:3M2128
|
4.4
|
24.6
|
0.2
|
CAI
|
B:3M2128
|
4.6
|
23.7
|
0.2
|
CAH
|
B:3M2128
|
4.7
|
24.9
|
0.2
|
CAG
|
B:3M2128
|
5.0
|
25.6
|
0.2
|
CAA
|
B:3M2128
|
5.0
|
33.1
|
0.2
|
|
Bromine binding site 8 out
of 12 in 3p3s
Go back to
Bromine Binding Sites List in 3p3s
Bromine binding site 8 out
of 12 in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 8 of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br128
b:36.0
occ:0.25
|
BRAE
|
B:3M2128
|
0.0
|
36.0
|
0.2
|
BRAF
|
B:3M2128
|
0.2
|
30.9
|
0.2
|
CAM
|
B:3M2128
|
1.9
|
25.5
|
0.2
|
CAN
|
B:3M2128
|
2.0
|
23.4
|
0.2
|
CAH
|
B:3M2128
|
2.7
|
24.9
|
0.2
|
CAK
|
B:3M2128
|
2.8
|
25.4
|
0.2
|
CAK
|
B:3M2128
|
2.8
|
25.4
|
0.2
|
OAD
|
B:3M2128
|
3.0
|
26.2
|
0.2
|
CAI
|
B:3M2128
|
3.1
|
23.7
|
0.2
|
OAD
|
B:3M2128
|
3.1
|
26.2
|
0.2
|
O
|
B:HOH155
|
3.6
|
41.4
|
1.0
|
CG2
|
B:THR106
|
3.9
|
22.1
|
1.0
|
CAL
|
B:3M2128
|
4.0
|
24.6
|
0.2
|
CAN
|
B:3M2128
|
4.1
|
23.4
|
0.2
|
CB
|
B:ALA108
|
4.1
|
17.8
|
1.0
|
CAM
|
B:3M2128
|
4.1
|
25.5
|
0.2
|
CG2
|
B:VAL121
|
4.2
|
21.2
|
1.0
|
CD
|
B:LYS15
|
4.3
|
23.4
|
1.0
|
O
|
B:HOH149
|
4.3
|
37.9
|
1.0
|
CAL
|
B:3M2128
|
4.4
|
24.6
|
0.2
|
CAI
|
B:3M2128
|
4.6
|
23.7
|
0.2
|
CAH
|
B:3M2128
|
4.7
|
24.9
|
0.2
|
CB
|
B:THR106
|
4.8
|
19.3
|
1.0
|
CAG
|
B:3M2128
|
5.0
|
25.6
|
0.2
|
NZ
|
B:LYS15
|
5.0
|
29.5
|
1.0
|
CAA
|
B:3M2128
|
5.0
|
33.1
|
0.2
|
|
Bromine binding site 9 out
of 12 in 3p3s
Go back to
Bromine Binding Sites List in 3p3s
Bromine binding site 9 out
of 12 in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 9 of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br128
b:30.9
occ:0.25
|
BRAF
|
B:3M2128
|
0.0
|
30.9
|
0.2
|
BRAE
|
B:3M2128
|
0.2
|
36.0
|
0.2
|
CAM
|
B:3M2128
|
1.7
|
25.5
|
0.2
|
CAN
|
B:3M2128
|
1.9
|
23.4
|
0.2
|
CAH
|
B:3M2128
|
2.6
|
24.9
|
0.2
|
CAK
|
B:3M2128
|
2.8
|
25.4
|
0.2
|
CAK
|
B:3M2128
|
2.8
|
25.4
|
0.2
|
CAI
|
B:3M2128
|
2.9
|
23.7
|
0.2
|
OAD
|
B:3M2128
|
3.0
|
26.2
|
0.2
|
OAD
|
B:3M2128
|
3.1
|
26.2
|
0.2
|
O
|
B:HOH155
|
3.8
|
41.4
|
1.0
|
CAL
|
B:3M2128
|
3.9
|
24.6
|
0.2
|
CG2
|
B:THR106
|
3.9
|
22.1
|
1.0
|
CB
|
B:ALA108
|
4.0
|
17.8
|
1.0
|
CAN
|
B:3M2128
|
4.0
|
23.4
|
0.2
|
CAM
|
B:3M2128
|
4.1
|
25.5
|
0.2
|
CG2
|
B:VAL121
|
4.2
|
21.2
|
1.0
|
CAL
|
B:3M2128
|
4.2
|
24.6
|
0.2
|
CD
|
B:LYS15
|
4.2
|
23.4
|
1.0
|
CAI
|
B:3M2128
|
4.4
|
23.7
|
0.2
|
O
|
B:HOH149
|
4.4
|
37.9
|
1.0
|
CAH
|
B:3M2128
|
4.6
|
24.9
|
0.2
|
CAG
|
B:3M2128
|
4.8
|
25.6
|
0.2
|
CAA
|
B:3M2128
|
4.8
|
33.1
|
0.2
|
CB
|
B:THR106
|
4.9
|
19.3
|
1.0
|
|
Bromine binding site 10 out
of 12 in 3p3s
Go back to
Bromine Binding Sites List in 3p3s
Bromine binding site 10 out
of 12 in the Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 10 of Human Transthyretin (Ttr) Complexed with (Z)-5-(3,5-Dibromo-4- Hydroxybenzylidene)-Imino-1-Methylimidazolidin-4-One within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br128
b:30.9
occ:0.25
|
BRAF
|
B:3M2128
|
0.0
|
30.9
|
0.2
|
BRAE
|
B:3M2128
|
0.2
|
36.0
|
0.2
|
CAM
|
B:3M2128
|
1.7
|
25.5
|
0.2
|
CAN
|
B:3M2128
|
1.9
|
23.4
|
0.2
|
CAH
|
B:3M2128
|
2.6
|
24.9
|
0.2
|
CAK
|
B:3M2128
|
2.8
|
25.4
|
0.2
|
CAK
|
B:3M2128
|
2.8
|
25.4
|
0.2
|
CAI
|
B:3M2128
|
2.9
|
23.7
|
0.2
|
OAD
|
B:3M2128
|
3.0
|
26.2
|
0.2
|
OAD
|
B:3M2128
|
3.1
|
26.2
|
0.2
|
NZ
|
B:LYS15
|
3.8
|
29.5
|
1.0
|
CAL
|
B:3M2128
|
3.9
|
24.6
|
0.2
|
CD1
|
B:LEU17
|
3.9
|
21.5
|
1.0
|
CAN
|
B:3M2128
|
4.0
|
23.4
|
0.2
|
CAM
|
B:3M2128
|
4.1
|
25.5
|
0.2
|
CE
|
B:LYS15
|
4.2
|
27.8
|
1.0
|
CAL
|
B:3M2128
|
4.2
|
24.6
|
0.2
|
CAI
|
B:3M2128
|
4.4
|
23.7
|
0.2
|
CAH
|
B:3M2128
|
4.6
|
24.9
|
0.2
|
CAG
|
B:3M2128
|
4.8
|
25.6
|
0.2
|
CAA
|
B:3M2128
|
4.8
|
33.1
|
0.2
|
|
Reference:
M.M.Alhamadsheh,
S.Connelly,
A.Cho,
N.Reixach,
E.T.Powers,
D.W.Pan,
I.A.Wilson,
J.W.Kelly,
I.A.Graef.
Potent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte Proteotoxicity. Sci Transl Med V. 3 7RA81 2011.
ISSN: ISSN 1946-6234
PubMed: 21865539
DOI: 10.1126/SCITRANSLMED.3002473
Page generated: Wed Jul 10 20:10:13 2024
|